September 5, 2007 Newsletter

Bigger Is Better

A series of acquisitions has transformed Commonwealth Biotechnologies into a larger company with a global presence in contract biotech research.

Henrico-based Bostwick Laboratories is expanding its medical lab services.

VCU Collaboration Across Countries

Delegates from China help in large-scale study on genetics and depression

Hepatitis C Cured, VCU Concludes

The current treatment for Hepatitis C can be considered a cure, VCU researcher announces. Disease is leading cause of cirrhosis, liver cancer and the need for transplants.

April 20, 2007, Newsletter

Breath of Fresh Air

PARI Respiratory's Richmond operation is developing a device that could bring welcome relief, and better health, to millions of patients with breathing tubes. 

You’ve come a long way, baby

Philip Morris redefines the tobacco company in an anti-smoking age

CBI Completes Mimotopes Acquisition

December 19, 2006, Newsletter

Bullish on Biotech

Richmond biotech start-ups are attracting venture capital from Silicon Valley, validating the region's emergence as an up-and-coming biotech center.

Tech Grows in Downtown

Officials hope Biotech Park will make Virginia a player in the industry.

Stem-cell Work at VCU

Scientists are hoping to learn to control functioning.

Insmed Gets Used to Biotech

June 1, 2006, Newsletter

No Gene is an Island. Genes do what they do in conjunction with other genes and proteins. The study of their interaction -- systems biology -- is one of the hot spots in life sciences and a strength of the Richmond, Va., biotech sector.

New Intellect at Intelliject. Eli Lilly veteran Spencer Williamson takes the helm at Intelliject, tasked with commercializing the firm's revolutionary auto-injector.    

“Ge m·u·t lich” in Richmond. Richmond gives a “warm, friendly” welcome to Hamburg-based m·u·t GmbH. 

Good for Romance, Great for the Heart. Levitra may help your love life, but a VCU researcher finds that it also can save your life life.  

January 7, 2006, Newsletter

Small Pharma. Atley Pharmaceuticals, a drug sales company reinventing itself as a value-added reseller, is enjoying unprecedented growth.  

Cancer-Killer Buckyballs. Metal-filled nano-particles developed at VCU improve medical imaging, target brain tumor cells for radiation therapy.

A New Era in Intensive Care. VCU starts construction on $192 million, state-of- the-art intensive care facility with no counterpart in Virginia.

Hydrocephalus Won't Get the Best of Us. VCU leads an international team developing treatment guidelines for NPH, a debilitating neurological disorder affecting 375,000 people in the United States.

August 29, 2005, Newsletter

Coping with Complexity. Pharmaceutical compounds are getting larger and more complicated. Boehringer- Ingelheim's R&D shop in Richmond figures out how to process them more efficiently.

Smokin'! Philip Morris USA will build a $300 million research center in the Virginia Biotechnology Research Park.

Tackling the Nursing Shortage. VCU Starts Construction on State-of-the-Art Nursing Education building.

VCU Capital Campaign Raises $82 Million. The university has achieved 85 percent of its 2007 goal to raise $330 million.

Brains and Smarts: Size Does Matter. VCU researcher finds strong correlation between brain size and intelligence. 

March 31, 2005, Newsletter

Today Prostates, Tomorrow the World. Bostwick Laboratories performs more prostate biopsies than any other lab -- anywhere. Such disciplined focus could well revolutionize the $35 billion-a-year medical lab business.

Medical School to Revive Focus. VCU officials aim to return research and development to the forefront of efforts.  

Breathing Life into Chemical Engineering. Michael Peters is transforming VCU’s chemical engineering department into an extension of the life sciences.

VCU'S “Global Player.” A professor in two departments, Anthony Guiseppi-Elie founded a biotechnology company and is widely known for his research.

Richmond : A Center for Health Care Innovation

December 7, 2004, Newsletter

Men in the Black. After five years of red ink, Commonwealth Biotechnologies is generating a profit. The VCU professors who founded the R&D outsourcing company now see a blue-sky future.

Where Engineering Meets Medicine. Medical research at an engineering school? You bet! Professors at the VCU School of Engineering are engaged in cutting-edge research that could improve the health and quality of life of millions.

I Vaannt to Suck Your PolyHeme. VCU investigates an experimental blood substitute for severely injured people.

A Kinder, Gentler Brain Surgery. Hmmm. You can bolt my skull to a metal frame. Or, you can rest a light plastic tower on my head... I'll take the plastic tower, please.

Alcohol Isn't the Only Thing That Kills Brain Cells.

Watch out for those calcium levels, researchers find.

September 14, 2004, Newsletter

Algae Agonist. Algae blooms are suffocating the Chesapeake Bay. Richmond’s Infilco Degremont is perfecting biological filters that remove the nutrients the noxious organisms feed upon.

Marketing Greater Richmond. Greater Richmond Partnership, Biotech Park Join Forces in San Francisco

Building a World-Class Institution. VCU unveils its 15-year Master Site Plan, defining its vision as major research university.

Trauma Transmitter. VCU professors prototype sensors that could improve the treatment of battlefield wounds.

Sure, it Looks Cool, But Can You Rest Your Coffee Mug on it? VCU Students develop "virtual clipboard" to aid professionals treating autism.

May 24, 2004, Newsletter

Cleaning Up With Clean Rooms: AdvanceTEC is thriving in the business of designing contamination-free work places. Its competitive advantages:  creativity and a willingness to take risk.

VCU to Offer Bioinformatics Degree: Only such program in Virginia.

Masters of Disaster:  VCU rolls out readiness program for first responders.

Don't Hear Ye, Don't Hear Ye: High rate of intermarriage among deaf people spreads birth defect, VCU researchers find.

January 12, 2004, Newsletter

Boosting Biotech in Bavaria. A Recent Life sciences seminar in Erlangen put Richmond's life sciences sector on the global map -- and laid the foundation for closer ties to the "Medical Valley of Germany."

A Chip in Time... may save lives. Tony Guiseppi-Elie is developing biochips that can be implanted in soldiers to monitor damage from battlefield trauma.